Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Allows Sale PeptoZIn From Lonza - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

FDA Allows Sale PeptoZIn From Lonza

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

FDA Allows Sale
PeptoZin™ From Lonza
FDA recently allowed the sale of PeptoZin TM, a new dietary ingredient from Lonza, Basel, Switzerland. PeptoZin is a complex of zinc and the dipeptide L-carnosine with unique biological activity different than that of zinc mixed with carnosine. In Japan, PeptoZin has been sold for over a decade as an ulcer-healing drug under the name Polaprezinc® (Zeria Pharmaceutical). Polaprezinc is manufactured by Hamari Chemical and enjoys abundant human and animal data. Lonza has an exclusive distribution agreement to market this patented ingredient in North America and Europe.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters